Mechanisms of immune dysregulation in human PI3Kgamma deficiency
人类 PI3Kgamma 缺乏症免疫失调的机制
基本信息
- 批准号:10265763
- 负责人:
- 金额:$ 12.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-14 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntibody FormationAntibody ResponseAsthmaAutoimmuneAutoimmune hemolytic anemiaAutoimmunityBLR1 geneBindingBiochemicalBiologyCD3 AntigensCD4 Positive T LymphocytesCXCL10 geneCXCL9 geneCXCR3 geneCatalytic DomainCell LineCellsChemotactic FactorsClinicalComplexCritical PathwaysDefectDevelopmentDiseaseEquilibriumExhibitsExposure toG-Protein-Coupled ReceptorsGenesGenomic DNAGoalsHousingHumanHuman BiologyHypersensitivityImmuneImmune System DiseasesImmune systemImmunocompetenceImmunologic Deficiency SyndromesIn VitroIndividualInfectionInfiltrationInflammationInflammatoryInheritedInterleukin-12InvestigationLettersLeukocytesLightLinkLoss of HeterozygosityLungLymphocyteMaintenanceModelingMononuclearMusMutationMyeloid CellsNaturePASLI diseasePIK3CG genePathologicPathway interactionsPatientsPatternPhagocytesPhenotypePhosphatidylinositolsPhosphotransferasesPhysiologicalPlayProcessProductionProteinsReportingResourcesRoleSerumSignal PathwaySignal TransductionStimulusStructure of germinal center of lymph nodeSyndromeT cell differentiationT cell responseT-Cell ActivationT-LymphocyteTestingTh1 CellsTherapeuticTissuesTranslational ResearchTumor-infiltrating immune cellsWorkcell behaviorchemokineclinical phenotypecongenital immunodeficiencycytokinecytopeniaexome sequencingforward geneticsgain of functiongain of function mutationgenetic manipulationhuman diseasehuman modelhypogammaglobulinemiaimmune healthimmunoregulationimprovedin vivoinnovationinsightinterleukin-23loss of function mutationmacrophagemonocytemouse modelnext generation sequencingnovelpathogenpathogen exposurepatient responseperipheral bloodpolarized cellprofiles in patientspublic health relevanceresponsetranslational modelunpublished works
项目摘要
Project Summary
Primary immunodeficiency diseases (PIDs) have great potential to provide mechanistic insights into the
molecules and pathways fundamentally important for maintenance of human immune health, and the unbiased
nature of forward genetics makes these studies particularly exciting to pursue. The phosphoinositide 3-kinase
(PI3K) signaling pathway plays important roles in many aspects of cell behavior within and outside the immune
system. Both gain-of-function and loss-of-function mutations in the genes encoding the p110δ and p85α PI3K
subunits have been identified in PID patients and have shed light on basic PI3K biology and underpinnings of
inherited immunodeficiency. However, no mutations in the other PI3K genes have been described in inherited
human disorders. We have now identified novel loss-of-function mutations in a new PI3K gene, PIK3CG, and
our preliminary studies highlight its importance in immune competence and regulation of tissue inflammation in
this disorder we have termed Inactivated PI3Kγ Syndrome (IPGS). Using primary human cells and cutting-edge
`dirty' mouse modeling approaches that recapitulate human disease by combining genetic manipulation and
natural pathogen exposure, two specific aims will be pursued. Aim 1) To define the roles for PI3Kγ in regulating
T cell-intrinsic and -extrinsic signals that modulate T cell activation and differentiation. Aim 2) To dissect the
mechanistic basis for antibody defects. The results of these investigations will provide significant insights into
this novel PID and PI3K signaling in general and will lay the groundwork to improve physiologically relevant
models for translational research in PIDs and other human disease contexts.
项目摘要
原发性免疫缺陷病(PID)具有很大的潜力,可以提供对免疫缺陷机制的深入了解。
分子和途径对维持人类免疫健康至关重要,
正向遗传学的性质使这些研究特别令人兴奋。磷酸肌醇3-激酶
(PI3K)信号通路在免疫内外细胞行为的许多方面起着重要作用。
系统编码p110 δ和p85 α PI3K基因的功能获得性和功能丧失性突变
亚基已经在PID患者中鉴定,并揭示了基本的PI3K生物学和
遗传性免疫缺陷然而,在其他PI3K基因中没有突变被描述为遗传性的。
人类疾病我们现在已经在一个新的PI3K基因PIK3CG中发现了新的功能丧失突变,
我们的初步研究强调了它在免疫能力和组织炎症调节中的重要性,
我们将这种疾病称为失活PI3K γ综合征(IPGS)。利用原代人体细胞和尖端技术
"脏"小鼠建模方法,通过结合遗传操作和
自然病原体暴露,将追求两个具体目标。目的:1)明确PI3K γ在细胞凋亡调控中的作用,
调节T细胞活化和分化的T细胞内在和外在信号。目的2)解剖
抗体缺陷的机制基础。这些调查的结果将提供重要的见解,
这种新的PID和PI3K信号一般,并将奠定基础,以改善生理相关的
在PID和其他人类疾病背景下的转化研究模型。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The role of PI3Kγ in the immune system: new insights and translational implications.
- DOI:10.1038/s41577-022-00701-8
- 发表时间:2022-11
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Maximizing insights from monogenic immune disorders.
- DOI:10.1016/j.coi.2021.09.008
- 发表时间:2021-12
- 期刊:
- 影响因子:7
- 作者:Barmada A;Ramaswamy A;Lucas CL
- 通讯作者:Lucas CL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carrie L. Lucas其他文献
“You Don’t Want to Be a Candidate for Punishment”: a Qualitative Analysis of LGBT Service Member “Outness”
《你不想成为受罚的候选人》:LGBT服役人员“外在性”的定性分析
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
K. McNamara;Carrie L. Lucas;Jeremy T. Goldbach;I. Holloway;C. Castro - 通讯作者:
C. Castro
Human genetic errors of immunity illuminate an adaptive arsenal model of rapid defenses
人类免疫基因缺陷揭示了快速防御的适应性武器库模型
- DOI:
10.1016/j.it.2023.12.006 - 发表时间:
2024-02-01 - 期刊:
- 影响因子:13.900
- 作者:
Carrie L. Lucas - 通讯作者:
Carrie L. Lucas
Mental health of the bisexual Veteran
双性恋退伍军人的心理健康
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:1.1
- 作者:
K. McNamara;Carrie L. Lucas;Jeremy T. Goldbach;Sara Kintzle;C. Castro - 通讯作者:
C. Castro
Military sexual assault (MSA) among veterans in Southern California: Associations with physical health, psychological health, and risk behaviors.
南加州退伍军人中的军事性侵犯 (MSA):与身体健康、心理健康和危险行为的关联。
- DOI:
10.1037/trm0000098 - 发表时间:
2017 - 期刊:
- 影响因子:3.2
- 作者:
A. Schuyler;Sara Kintzle;Carrie L. Lucas;Hadass Moore;C. Castro - 通讯作者:
C. Castro
PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond
PI3Kδ通路失调以及来那利西布在活化的PI3Kδ综合征及其他病症中对该通路抑制作用的独特特征
- DOI:
10.1016/j.jaip.2023.09.016 - 发表时间:
2024-01-01 - 期刊:
- 影响因子:6.600
- 作者:
Andrew J. Cant;Anita Chandra;Ewen Munro;V. Koneti Rao;Carrie L. Lucas - 通讯作者:
Carrie L. Lucas
Carrie L. Lucas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carrie L. Lucas', 18)}}的其他基金
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
新型单基因转录因子缺陷阐明粘膜自身炎症的机制
- 批准号:
10393682 - 财政年份:2021
- 资助金额:
$ 12.56万 - 项目类别:
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
新型单基因转录因子缺陷阐明粘膜自身炎症的机制
- 批准号:
10211252 - 财政年份:2021
- 资助金额:
$ 12.56万 - 项目类别:
Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect
新型单基因转录因子缺陷阐明粘膜自身炎症的机制
- 批准号:
10589909 - 财政年份:2021
- 资助金额:
$ 12.56万 - 项目类别:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
人类 PI3Kgamma 缺乏症免疫失调的机制
- 批准号:
10178863 - 财政年份:2020
- 资助金额:
$ 12.56万 - 项目类别:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
人类 PI3Kgamma 缺乏症免疫失调的机制
- 批准号:
9896405 - 财政年份:2020
- 资助金额:
$ 12.56万 - 项目类别:
Mechanisms of immune dysregulation in human PI3Kgamma deficiency
人类 PI3Kgamma 缺乏症免疫失调的机制
- 批准号:
10088389 - 财政年份:2020
- 资助金额:
$ 12.56万 - 项目类别:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
DNA 损伤反应激酶 CHK1 在 TCR/ITAM 信号传导中的新作用
- 批准号:
9983879 - 财政年份:2018
- 资助金额:
$ 12.56万 - 项目类别:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
DNA 损伤反应激酶 CHK1 在 TCR/ITAM 信号传导中的新作用
- 批准号:
10417180 - 财政年份:2018
- 资助金额:
$ 12.56万 - 项目类别:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
DNA 损伤反应激酶 CHK1 在 TCR/ITAM 信号传导中的新作用
- 批准号:
9612779 - 财政年份:2018
- 资助金额:
$ 12.56万 - 项目类别:
Novel roles for the DNA damage response kinase CHK1 in TCR/ITAM signaling
DNA 损伤反应激酶 CHK1 在 TCR/ITAM 信号传导中的新作用
- 批准号:
10330648 - 财政年份:2018
- 资助金额:
$ 12.56万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 12.56万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 12.56万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 12.56万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 12.56万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 12.56万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 12.56万 - 项目类别:














{{item.name}}会员




